Your doctor may monitor you for breathing problems during your treatment with BOTOX® for spasticity or for detrusor overactivity associated with a neurologic condition.

The FDA has approved Botox for the treatment of lower limb spasticity in pediatric patients 2 to 17 years of age, excluding spasticity caused by cerebral palsy. The treatment was already approved ...

The FDA approved Botox for lower-limb spasticity on the basis of safety and efficacy data from a phase 3 study involving more than 300 children aged 2 years or older with lower-limb spasticity ...

BOTOX® was first approved for the treatment of upper limb spasticity (ULS), or increased muscle stiffness in the elbow, wrist and fingers, in adults in March 2010.

Botox Injections Effective For Treating Stroke Spasticity Date: October 29, 2005 Source: Wake Forest University Baptist Medical Center Summary: New research shows that repeated treatments of ...

Botox is the first neurotoxin to be approved in the US to treat upper limb spasticity for pediatric patients aged 2 years and older.

The FDA has approved a label expansion for Botox to include eight new muscles and the use of ultrasound for the treatment of upper limb spasticity in adults, according to a press release.Botox ...

The FDA has set a Prescription Drug User Fee Act (PDUFA) date for the upper limb pediatric spasticity indication in the second quarter of 2019; the PDUFA date for the lower limb pediatric ...

Allergan Inc said on Tuesday that U.S. health regulators will require more information before approving its Botox anti-wrinkle drug as a treatment for upper limb spasticity in stroke victims.

The safety and efficacy of BOTOX ® as treatment for lower limb spasticity for pediatric patients is supported by a Phase 3 study with more than 300 patients two to 17 years of age with lower limb ...

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity ...